Humacyte Inc
(NAS:HUMA)
$
7.03
0.63 (9.84%)
Market Cap: 839.04 Mil
Enterprise Value: 763.40 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 38/100 Humacyte Inc (HUMA) Transcripts
- Q1 2024 Humacyte Inc Earnings Call TranscriptMay 10, 2024$4.7 (+3.98%)Earnings
- Q4 2023 Humacyte Inc Earnings Call TranscriptMar 22, 2024$3.31 (-8.06%)Earnings
- Q3 2023 Humacyte Inc Earnings Call TranscriptNov 09, 2023$2.21 (+0.91%)Earnings
- Humacyte Inc To Host KOL And Patient Perspectives Event TranscriptSep 20, 2023
- Humacyte Inc Top Line Data Announcement TranscriptSep 12, 2023
- Q2 2023 Humacyte Inc Earnings Call TranscriptAug 14, 2023$4.04 (+23.55%)Earnings
- Q1 2023 Humacyte Inc Earnings Call TranscriptMay 12, 2023$3.97 (-6.48%)Earnings
- Humacyte Inc at H.C. Wainwright BioConnect Investor Conference TranscriptMay 02, 2023
- Q4 2022 Humacyte Inc Earnings Call TranscriptMar 24, 2023$2.91 (-5.83%)Earnings
- Humacyte Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 14, 2023
- Humacyte Inc at Cowen Health Care Conference TranscriptMar 06, 2023
- Humacyte Inc At Emerging Growth Conference (Virtual) TranscriptFeb 08, 2023
- Humacyte Inc KOL Webinar: Ukrainian Surgeons Discuss Use of HAV in Wartime TranscriptDec 15, 2022
- Q3 2022 Humacyte Inc Earnings Call TranscriptNov 10, 2022$3.26 (+3.82%)Earnings
- Q4 2021 Humacyte Inc Earnings Call TranscriptMar 29, 2022$6.73 (+5.65%)Earnings
- 1